Shira Wieder

795 citations
12 papers · 579 indexed · h-index 7
Topics
Cell death mechanisms and regulation (2 papers)Mitochondrial Function and Pathology (2 papers)ATP Synthase and ATPases Research (2 papers)
Partner nations
United StatesGermany

In The Last Decade

Shira Wieder

9 papers receiving 575 citations

Peers

Shira Wieder
Comparison fields: 5 of 73
  • Molecular Biology 479
  • Cancer Research 161
  • Epidemiology 80
  • Oncology 68
  • Cell Biology 50
Replace Rana Elkholi with:
Rana Elkholi United States
Francesco Ciscato Italy
Jeff Bruce Canada
Lei Du China
Lindsey J. Myers United States
Sun Mi Hong South Korea
Aristeidis E. Boukouris Canada
Danilo Faccenda United Kingdom
Avi Kumar United States
Anastasia A. Khutornenko Russia
Shira Wieder relative to Rana Elkholi United States Rana Elkholi's profile →
Citations per field
00.5×1.5×
Rana Elkholi · 1×
Citations per year

Countries citing papers authored by Shira Wieder

Since Specialization
Citations

This map shows the geographic impact of Shira Wieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shira Wieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shira Wieder more than expected).

Fields of papers citing papers by Shira Wieder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shira Wieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shira Wieder. The network helps show where Shira Wieder may publish in the future.

Co-authorship network of co-authors of Shira Wieder

This figure shows the co-authorship network connecting the top 25 collaborators of Shira Wieder. A scholar is included among the top collaborators of Shira Wieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shira Wieder. Shira Wieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 0
2 1
3 0
4 15
5 321
6 7
7 47
8 162
9 6
10 0
11 17
12
Team effort: psychosocial support program for patients with breast cancer at Montefiore Hospital.
3

About Shira Wieder

Shira Wieder is a scholar working on Rheumatology, Virology and Immunology, having authored 12 papers that have together received 579 indexed citations. Recurring topics across this work include Cell death mechanisms and regulation (2 papers), Mitochondrial Function and Pathology (2 papers) and ATP Synthase and ATPases Research (2 papers). The work is most often cited by research in Cancer Research (161 citations), Molecular Biology (479 citations) and Clinical Biochemistry (46 citations). Shira Wieder has collaborated with scholars based in United States and Germany. Frequent co-authors include Jerry E. Chipuk, James J. Asciolla, Madhavika N. Serasinghe, Thibaud T. Renault, Rana Elkholi, Kyle L. Hoehn, Hiromi Sesaki, Yusuke Kageyama, Omar Jabado and Yulia Kushnareva. Their work appears in journals such as JAMA, Blood and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026